Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
PTGX
#1031
Protagonist Therapeutics, Inc
92.080
0
+6.88%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
+6.88%
Monthly Change
+11.68%
6 month change
+22.56%
Year Change
+22.56%
Previous Close
86.150
0
Open
92.210
0
Bid
Ask
Low
92.080
0
High
92.220
0
Volume
152
Markets
US Stock Market
Healthcare
PTGX
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Dividends per share
—
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
—
News
Protagonist Therapeutics earnings missed by $0.35, revenue fell short of estimates
Citizens raises Protagonist Therapeutics stock price target on drug approvals
Protagonist Therapeutics director Williams sells $1.48 million in shares
Protagonist Therapeutics director sells $1.67 million in shares
Top Biotech Stocks to Watch in 2026, According to Truist
Protagonist Therapeutics stock price target raised to $117 from $80 at H.C. Wainwright
Protagonist Stock: Assessing The 2026 Upside For Icotrokinra And Rusfertide (PTGX)
Ali Asif, CFO of protagonist, sells $3.8m in PTGX stock
Protagonist Therapeutics CEO Patel sells $4m in shares
Protagonist Therapeutics chief medical officer sells $1.9m in shares
JPMorgan reiterates Overweight rating on Protagonist Therapeutics stock
Wednesday’s Insider Activity: Top Buys and Sells for January 21